FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2045433422> ?p ?o ?g. }

• W2045433422 endingPage "66" @default.
• W2045433422 startingPage "62" @default.
• W2045433422 abstract "Pyrazine diazohydroxide (NSC 361456) (PZDH) was selected for further development after demonstrating more stability than its parent compound and significant antitumor activity in a number of in vivo tumor models. Its proposed mechanism of action is through the formation of DNA adducts via the reactive pyrazine diazonium ion. The aim of this phase II trial was to determine the toxicity and antitumor activity of PZDH in advanced non small-cell lung cancer (NSCLC). From May 1995 through April 1996, 17 chemo-therapy-naive patients were entered into this study. PZDH was administered via a 5-minute intravenous bolus injection at a dose of 100 mg/m2 for 5 days and repeated every 42 days. Per interim guidelines, the study was closed early due to lack of activity. Seventeen patients were evaluable for toxicity while 15 patients were evaluable for response. The median number of cycles administered was 2 (range, 1-7). Toxicity was moderate with grade 3-4 thrombocytopenia being the most common and occurring in six of 17 patients. Of the 15 patients evaluable for response, no partial or complete responses were observed (95% confidence interval [CI]: 0%-22%), while seven patients had stable disease and eight patients progressed during therapy. All but one patient have died. The median survival for the group is 6.6 months (95% CI: 3.4-10.8 months). PZDH possesses modest but acceptable hematologic toxicity when delivered at the above dose and dosing scheme. Our results demonstrate that PZDH has no clinical activity in advanced NSCLC with this dose and schedule." @default.
• W2045433422 created "2016-06-24" @default.
• W2045433422 creator A5010216039 @default.
• W2045433422 creator A5031045282 @default.
• W2045433422 creator A5032064458 @default.
• W2045433422 creator A5050522029 @default.
• W2045433422 creator A5055271621 @default.
• W2045433422 creator A5072600408 @default.
• W2045433422 date "2000-08-01" @default.
• W2045433422 modified "2023-09-26" @default.
• W2045433422 title "Phase II Study of Pyrazine Diazohydroxide (NSC 361456) for Advanced Non–Small-Cell Lung Cancer" @default.
• W2045433422 cites W1483594681 @default.
• W2045433422 cites W1973262735 @default.
• W2045433422 cites W2002294162 @default.
• W2045433422 cites W2015412192 @default.
• W2045433422 cites W2029409133 @default.
• W2045433422 cites W2049844842 @default.
• W2045433422 cites W2059020146 @default.
• W2045433422 cites W2089170198 @default.
• W2045433422 cites W2092941680 @default.
• W2045433422 cites W2099933670 @default.
• W2045433422 cites W2101038194 @default.
• W2045433422 cites W2116150717 @default.
• W2045433422 cites W2160966202 @default.
• W2045433422 cites W2172063739 @default.
• W2045433422 cites W2321433368 @default.
• W2045433422 cites W2463123398 @default.
• W2045433422 cites W2473805460 @default.
• W2045433422 cites W43260938 @default.
• W2045433422 doi "https://doi.org/10.3816/clc.2000.n.019" @default.
• W2045433422 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14731342" @default.
• W2045433422 hasPublicationYear "2000" @default.
• W2045433422 type Work @default.
• W2045433422 sameAs 2045433422 @default.
• W2045433422 citedByCount "1" @default.
• W2045433422 countsByYear W20454334222012 @default.
• W2045433422 crossrefType "journal-article" @default.
• W2045433422 hasAuthorship W2045433422A5010216039 @default.
• W2045433422 hasAuthorship W2045433422A5031045282 @default.
• W2045433422 hasAuthorship W2045433422A5032064458 @default.
• W2045433422 hasAuthorship W2045433422A5050522029 @default.
• W2045433422 hasAuthorship W2045433422A5055271621 @default.
• W2045433422 hasAuthorship W2045433422A5072600408 @default.
• W2045433422 hasConcept C121608353 @default.
• W2045433422 hasConcept C126322002 @default.
• W2045433422 hasConcept C143998085 @default.
• W2045433422 hasConcept C150903083 @default.
• W2045433422 hasConcept C207001950 @default.
• W2045433422 hasConcept C2776256026 @default.
• W2045433422 hasConcept C2776694085 @default.
• W2045433422 hasConcept C2777288759 @default.
• W2045433422 hasConcept C2781047374 @default.
• W2045433422 hasConcept C29730261 @default.
• W2045433422 hasConcept C31760486 @default.
• W2045433422 hasConcept C43376680 @default.
• W2045433422 hasConcept C535046627 @default.
• W2045433422 hasConcept C61943457 @default.
• W2045433422 hasConcept C71924100 @default.
• W2045433422 hasConcept C86803240 @default.
• W2045433422 hasConcept C90924648 @default.
• W2045433422 hasConcept C98274493 @default.
• W2045433422 hasConceptScore W2045433422C121608353 @default.
• W2045433422 hasConceptScore W2045433422C126322002 @default.
• W2045433422 hasConceptScore W2045433422C143998085 @default.
• W2045433422 hasConceptScore W2045433422C150903083 @default.
• W2045433422 hasConceptScore W2045433422C207001950 @default.
• W2045433422 hasConceptScore W2045433422C2776256026 @default.
• W2045433422 hasConceptScore W2045433422C2776694085 @default.
• W2045433422 hasConceptScore W2045433422C2777288759 @default.
• W2045433422 hasConceptScore W2045433422C2781047374 @default.
• W2045433422 hasConceptScore W2045433422C29730261 @default.
• W2045433422 hasConceptScore W2045433422C31760486 @default.
• W2045433422 hasConceptScore W2045433422C43376680 @default.
• W2045433422 hasConceptScore W2045433422C535046627 @default.
• W2045433422 hasConceptScore W2045433422C61943457 @default.
• W2045433422 hasConceptScore W2045433422C71924100 @default.
• W2045433422 hasConceptScore W2045433422C86803240 @default.
• W2045433422 hasConceptScore W2045433422C90924648 @default.
• W2045433422 hasConceptScore W2045433422C98274493 @default.
• W2045433422 hasIssue "1" @default.
• W2045433422 hasLocation W20454334221 @default.
• W2045433422 hasLocation W20454334222 @default.
• W2045433422 hasOpenAccess W2045433422 @default.
• W2045433422 hasPrimaryLocation W20454334221 @default.
• W2045433422 hasRelatedWork W1426247572 @default.
• W2045433422 hasRelatedWork W1858072261 @default.
• W2045433422 hasRelatedWork W2004453394 @default.
• W2045433422 hasRelatedWork W2013302072 @default.
• W2045433422 hasRelatedWork W2018593099 @default.
• W2045433422 hasRelatedWork W2020532650 @default.
• W2045433422 hasRelatedWork W2034899869 @default.
• W2045433422 hasRelatedWork W2040084516 @default.
• W2045433422 hasRelatedWork W2043004167 @default.
• W2045433422 hasRelatedWork W2045335497 @default.
• W2045433422 hasRelatedWork W2062995596 @default.
• W2045433422 hasRelatedWork W2069469795 @default.
• W2045433422 hasRelatedWork W2138564627 @default.
• W2045433422 hasRelatedWork W2149212053 @default.

• next